Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: Association with placental improvement

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 70, Issue 11, 2004, Pages 862-869

  Prater, Mary Renee ^a,b   Zimmerman, Kurt Lee ^b   Ward, Daniel Lee ^b   Holladay, Steven David ^b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

CD 1 mouse; Developmental immunotoxicology; Digit; Interferon gamma; Limb; Methylnitrosourea; Placenta

Indexed keywords

GAMMA INTERFERON; METHYLNITROSOUREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH DEFECT; CLUBBING FINGERS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS DISEASE; FINGER MALFORMATION; GESTATIONAL AGE; IMMUNOSTIMULATION; INCIDENCE; INNER EAR; LIMB; MALE; MORPHOLOGY; MOUSE; NONHUMAN; OLIGODACTYLIA; PLACENTA; POLYDACTYLY; PRIORITY JOURNAL; SYNDACTYLY; TROPHOBLAST; WEBBED NECK;

ABNORMALITIES, DRUG-INDUCED; ALKYLATING AGENTS; ANIMALS; DRUG THERAPY, COMBINATION; EAR, INNER; ENDOTHELIAL CELLS; FEMALE; IMMUNE SYSTEM; INTERFERON TYPE II; LIMB DEFORMITIES, CONGENITAL; MALE; MATERNAL-FETAL EXCHANGE; METHYLNITROSOUREA; MICE; PLACENTA; PREGNANCY; TROPHOBLASTS;

EID: 10044233911     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.20082     Document Type: Article

References (42)

1. Akaike M, Ohno H, Tsutsumi S, Omosu M. 1994. Comparison of four spatial maze learning tests with methylnitrosourea-induced microcephaly rats. Teratology 49:83-89.
2. Ashkar AA, Di Santo JP, Croy BA. 2000. Interferon-g contributes to initiation of uterine vascular modifications, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 17:259-269.
3. Bochert G, Platzek T, Blankenburg G, et al. 1985. Embryotoxicity induced by alkylating agents: left-sided preponderance of paw malformations induced by acetoxymethyl-methylnitrosamine in mice. Arch Toxicol 56:139-150.
4. Bossert NL, Iannaccone PM. 1985. Midgestational abnormalities associated with in vitro preimplantation N-methyl-N-nitrosourea exposure with subsequent transfer to surrogate mothers. Proc Natl Acad Sci USA 82:8757-8761.
5. Cencic A, Guillomot M, Koren S, LaBonnardiere C. 2003. Trophoblastic interferons: do they modulate uterine cellular markers at the time of conceptus attachment in the pig? Placenta 24:862-869.
6. Dumas JC, Giroux M, Teixeira MG, et al. 1993. Study of the transplacental transfer of interferon alfa-2a on the model of isolated perfused cotyledon. Therapie 48:73-75.
7. Fantel AG, Person RE. 2002. Further evidence for the role of free radicals in the limb teratogenicity of L-NAME. Teratology 66:24-32.
8. Fleming A, Copp AJ. 1998. Embryonic folate metabolism and mouse neural tube defects. Science 280:2107-2109.
9. Fujimori K, Inoue K, Nakazawa K, et al. 1992. Neurochemical and histological analysis of motor dysfunction observed in rats with methylnitrosourea-induced experimental cerebellar hypoplasia. Neurochem Res 17:223-231.
10. Holers VM, Girardi G, Mo L, et al. 2002. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195:211-220.
11. Holladay SD, Sharova L, Smith BJ, et al. 2000. Nonspecific stimulation of the maternal immune system. I. Effects on teratogen-induced fetal malformations. Teratology 62:413-419.
12. Holladay SD, Sharova LV, Punareewattana K, et al. 2002. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. Int Immunopharmacol 2:325-332.
13. Huang PH, Catalano A. 1992. N-alkyl-N-nitrosourea induced secondary structural changes in DNA from rat embryos and fetal brains in vivo. Teratog Carcinog Mutagen 12:135-153.
14. Iannaccone PM, Tsao TY, Stols L. 1982. Effects on mouse blastocysts of in vitro exposure to methylnitrosourea and 3-methylcholanthrene. Cancer Res 42:864-868.
15. Ishimura R, Ohsako S, Kawakami T, et l. 2002. Altered protein profile and possible hypoxia-in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed rats. Toxicol Appl Pharmacol 185:197-206.
16. Kaelbling M, Zhang YD, Dasgupta UB, et al. 1991. Nonrandom chromosome changes in methylnitrosourea (MNU) induced mouse T-cell lymphomas. Ann Genet 34:270-278.
17. Kobayashi-Miura M, Nakamura H, Yodoi J, Shiota K. 2002. Thioredoxin, an anti-oxidant protein, protects mouse embryos from oxidative stress-induced developmental anomalies. Free Radic Res 36:949-956.
18. Lane RH, Ramirez RJ, Tsirka AE, et al. 2001. Uteroplacental insufficiency lowers the threshold towards hypoxia-induced cerebral apoptosis in growth-retarded fetal rat. Brain Res 895:186-193.
19. Lee JS, Park EH, Choe J, Chipman JK. 2000. N-methyl-n-nitrosourea (MNU) induces papillary thyroid tumours which lack ras gene mutations in the hermaphroditic fish Rivulus marmoratus. Teratog Carcinog Mutagen 20:1-9.
20. Loch-Caruso R, Baxter CS. 1984. DNA damage and repair in embryonic mouse limbs exposed to teratogenic doses of methylnitrosourea. Mutat Res 131:147-155.
21. Mahapatra PK, Mohanty-Hejmadi P, Chainy GB. 2001. Specific limb abnormalities induced by hydrogen peroxide in tadpoles of Indian jumping frog. Polypedates macularus. Indian J Exp Biol 39:1103-1106.
22. Murata M, Takahashi A, Saito I, Kawanishi S. 1999. Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozoticin. Biochem Pharmacol 57:881-887.
23. Nagao T, Morita Y, Ishizuka Y, et al. 1991. Induction of fetal malformations after treatment of mouse embryos with methylnitrosourea at the preimplantation stages. Teratog Carcinog Mutagen 11:1-10.
24. Nomura T, Hata S, Kusafuka T. 1990. Suppression of developmental anomalies by maternal macrophages in mice. J Exp Med 172:1325-1330.
25. Peng Y, Yang PH, Guo Y, et al. 2004. Catalase and peroxiredoxin 5 protect Xenopus embryos against alcohol-induced ocular anomalies. Invest Ophthalmol Vis Sci 45:23-29.
26. Platzek T, Bochert G, Pauli B, et al. 1988. Embryotoxicity induced by alkylating agents: 5. Dose-response relationships of teratogenic effects of methylnitrosourea in mice. Arch Toxicol 62:411-423.
27. Punareewattana K, Holladay SD. 2004. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-gamma reduces severity of diabetic embryopathy in ICR mice. Birth Defects Res Part A Clin Mol Teratol 70:20-27.
28. Rhim JS, Jin S, Jung M, et al. 1997. Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. Cancer Res 57:576-580.
29. Saito S. 2001. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 52:15-33.
30. Savion S, Brengauz-Breitmann M, Torchinsky A, Toder V. 1999. A possible role for granulocyte macrophage-colony stimulating factor in modulating teratogen-induced effects. Teratog Carcinog Mutagen 19:171-182.
31. Sen NP, Seaman SW, Burgess C, et al. 2000. Investigation on the possible formation of N-nitroso-N-methylurea by nitrosation of creatinine in model systems and in cured meats at gastric pH. J Agric Food Chem 48:5088-5096.
32. Sharova L, Sura P, Smith BJ, et al. 2000. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology 62:420-428.
33. Sharova LV, Sharova AA, Sura P, et al. 2003. Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth-factor and cell cycle gene expression caused by urethane: are these events related to reduced teratogenesis? Int Immunopharmacol 3:945-955.
34. Smith SB, O'Brein PJ. 1988. Biochemical characterization of retinal protein and phospholipid synthesis in mice exposed transplacentally to N-methyl-N-nitrosourea. Exp Eye Res 47:713-725.
35. Smith SB, Cooke CB, Yielding KL. 1988. Effects of the antioxidant butylated hydroxytoluene (BHT) on retinal degeneration induced transplacentally by a single low dosage of N-methyl-N-nitrosourea (MNU). Teratog Carcinog Mutagen 8:175-189.
36. Sukumar S, Barbacid M. 1990. Specific patterns of oncogene activation in induced tumors. Proc Natl Acad Sci USA 87:718-722.
37. Tanaka T, Fujitani T, Takahashi O, et al. 1995. Developmental toxicity study of piperonyl butoxide in CD rats. Toxicol Ind Health 11:175-184.
38. Thompson TA, Haag JD, Gould MN. 2000. Ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats. Carcinogenesis 21:1917-1922.
39. Toder V, Savion S, Gorivodsky M, et al. 1996. Teratogen-induced apoptosis may be affected by immunopotentiation. J Reprod Immunol 30:173-185.
40. Torchinsky A, Toder V, Savion S, et al. 1997. Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus. Diabetologia 40:635-640.
41. Uthoff H, Spenner A, Reckelkamm W, et al. 2003. Critical role of preconceptional immunization for protective and nonpathological specific immunity in murine neonates. J Immunol 171:3485-3492.
42. Weksler-Zangen S, Yaffe P, Ornoy A. 2003. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions. Birth Defects Res Part A Clin Mol Teratol 67:429-437.